New Alzheimer’s Drugs
Two Alzheimer’s drugs, donanemab (Kisunla) and lecanemab (Leqembi) appear to hold real promise in slowing the progression of the Alzheimer’s disease. Both drugs are designed for individuals in the early stages of the disease, and work by reducing amyloid plaques (or abnormal protein build-ups in the brain that are linked to the disease.) Donanemab, a
Recent Comments